While impaired JAK/STAT5 signaling contributes to the development of polycystic kidney disease and chronic kidney disease, podocyte STAT5 ameliorates focal segmental glomerulosclerosis.19–21 Only one poster publication indicates protective role of STAT5 in acute, cisplatin-induced injury model.22 Here, STAT5B is linked to chronic kidney disease.